Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Short-term Investments (2023 - 2025)

Connect Biopharma Holdings' Short-term Investments history spans 2 years, with the latest figure at $16.9 million for Q3 2025.

  • For Q3 2025, Short-term Investments changed N/A year-over-year to $16.9 million; the TTM value through Sep 2025 reached $16.9 million, changed N/A, while the annual FY2024 figure was $15.5 million, N/A changed from the prior year.
  • Short-term Investments for Q3 2025 was $16.9 million at Connect Biopharma Holdings, down from $31.1 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $36.3 million in Q1 2025 and bottomed at $15.5 million in Q4 2024.